beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc

Term ID

CHEBI:62994

Synonyms

(Gal)2 (GlcNAc)2
beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose
beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-D-glucosamine
beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-GlcpNAc
beta-Gal1,3-beta-GlcNAc1,3-beta-Gal1,4-GlcNAc
Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAc

Definition

A tetrasaccharide comprising residues of galactose, N-acetylglucosamine, galactose and N-acetylglucosamine units in a linear sequence, all joined by β-linkages.

References

glygen:G62942HO
glytoucan:G62942HO
kegg.glycan:G01494
pubmed:6208947

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc

Phenotype where environments contain beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc

Phenotype modified by environments containing beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc

Phenotype affecting beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc

Human Disease Model